Activist Investor Saba Capital Reduces Stake by $19 Million
ECAT sits 16% above its 52-week low of $13.36.
Summary
Activist investor Saba Capital Management sold 1.16 million shares of BlackRock ESG Capital Allocation Term Trust for approximately $19 million, reducing its stake to 18.03%.
Key Events · Ownership and Investor Activity · ECAT
-
Significant Share Sales
Saba Capital Management sold 1,164,297 shares of common stock between June 2 and June 25, 2026.
-
Total Proceeds from Sales
The sales generated approximately $18.97 million in proceeds.
-
Reduced Ownership Stake
Saba Capital's beneficial ownership is now 17,930,744 shares, representing 18.03% of the outstanding common stock.
-
Ongoing Activist Activity
This filing is Amendment No. 35, indicating a continued active position and adjustments by Saba Capital, following a recent proxy contest.
Analysis · ECAT · Unknown
Saba Capital Management, an activist investor, has continued to reduce its stake in BlackRock ESG Capital Allocation Term Trust by selling approximately 1.17% of the outstanding shares for nearly $19 million. This ongoing reduction in holdings by a significant activist investor could signal a shift in their strategy or a lack of confidence in the current valuation or management's direction, especially following a recent proxy contest.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 29.4% of the 1637 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ECAT was trading at $15.51 on NYSE in the Unknown sector. The 52-week trading range was $13.36 to $17.14. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.